ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.23
0.00%
US Tech 100
19,172.00
-0.04%
S&P 500
5,550.33
0.10%
US Dollar vs CAD
1.3741
0.27%
Bitcoin
64,715.33
1.17%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pulse Biosciences Inc (PLSE)

  7. Pulse Biosciences Inc (PLSE) News

PLSE

Pulse Biosciences (PLSE)

Pulse Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLSE
DateTimeSourceHeadlineSymbolCompany
07/15/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
07/15/20246:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PLSEPulse Biosciences Inc
07/15/20245:05AMEdgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:PLSEPulse Biosciences Inc
07/09/20248:12AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
07/08/20248:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
07/08/20248:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
07/08/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
07/08/20247:00AMBusiness WirePulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial FibrillationNASDAQ:PLSEPulse Biosciences Inc
07/03/20241:44PMBusiness WirePulse Biosciences, Inc. Announces the Closing of its Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
06/28/20247:00AMBusiness WirePulse Biosciences, Inc. Announces Preliminary Results for its Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
06/07/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
06/04/20243:05PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:PLSEPulse Biosciences Inc
06/04/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
06/02/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PLSEPulse Biosciences Inc
05/31/20243:18PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:PLSEPulse Biosciences Inc
05/28/20244:19PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PLSEPulse Biosciences Inc
05/22/20241:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
05/22/20241:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
05/20/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
05/20/20243:05PMBusiness WirePulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
05/16/20247:00AMBusiness WirePulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingNASDAQ:PLSEPulse Biosciences Inc
05/15/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
05/14/20243:05PMBusiness WirePulse Biosciences Enhances Executive Leadership TeamNASDAQ:PLSEPulse Biosciences Inc
05/09/20248:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
05/09/20247:00AMBusiness WirePulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
05/07/20243:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
05/07/20243:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
05/07/20243:05PMBusiness WirePulse Biosciences Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
05/02/20247:00AMBusiness WirePulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
04/24/20243:05PMBusiness WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024NASDAQ:PLSEPulse Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PLSE

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
SPZI
Spooz (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
ITUP
Interups (CE)
USOTC
CNNA
Cann American (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
HIRU
Hiru (PK)
USOTC
GDVM
Global Developments (PK)
NYSE
AMC
AMC Entertainment
USOTC
ILUS
Ilustrato Pictures (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
DRNK
NoHo (PK)
USOTC
MONI
Moon Equity (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved